Table of Contents Table of Contents
Previous Page  3 / 62 Next Page
Information
Show Menu
Previous Page 3 / 62 Next Page
Page Background

i

NCCN Guidelines for Patients

®

Breast Cancer - Carcinoma in Situ

(stage 0)

, Version 1.2016

NCCN Guidelines for Patients

®

Version 1.2016

Support from

NCCN and NCCN Foundation –

Boards of Directors

Drs. Al B. Benson III and Alanah Fitch

Joshua and Stephanie Bilenker

Dr. and Mrs. Douglas W. Blayney

Mara Bloom

Rebecca Caires, MBA

Peter F. Coccia, MD and Phyllis I. Warkentin, MD

Gena Cook

Dr. and Mrs. Thomas A. D’Amico

Dr. and Mrs. Timothy J. Eberlein

Paul F. Engstrom

David S. Ettinger, MD, FACP, FCCP

Theresa J. Franco, RN, MSN

Brian Garofalo

Jack A. Gentile, Jr.

Matt Kalaycio, MD

Mark F. Kochevar and Barbara Redmond

Heather Kopecky

Trisha Lollo

Ray Lynch, CPA, MBA

James and Marilyn Mohler

Lisle M. Nabell, MD

Michael and Gwyneth Neuss

Michael Parisi, MBA, MA

Barbara Parker, MD

Lori C Pickens, MHA

Dorothy Puhy

Denise K. Reinke, MS, NP

Marc Samuels

Gerrie Shields

Dr. and Mrs. Samuel Silver

Susan C. & Robert P. Stein

The Honorable Ellen O. Tauscher

Jeff and Colleen Walker

Robert C. Young, MD

NCCN AND NCCN Foundation –

staff contributing $100

or more

Anonymous

Robert W. Carlson, MD and Stacey Starcher

C. Lyn Fitzgerald, MJ

Kristina Gregory

Joseph Junod

Lisa G. Kimbro, MBA, CPA

Joan S. McClure

Elizabeth Nardi

Marcie Reeder, MPH

Gary J. and Marianne Weyhmuller

An additional fifty-five (55) donations were

received from other NCCN staff members.

Endorsed by

breast cancer alliance

Receiving a cancer diagnosis can be

overwhelming, both for the patient and their

family. We support the NCCN guidelines for

breast cancer with the knowledge that these

tools will help to equip patients with many of the

educational resources, and answers to questions,

they may seek.

www.breastcanceralliance.org

FORCE: Facing Our Risk of

Cancer Empowered

As the nation’s leading organization serving the

heredtiary breast and ovarian cancer community,

FORCE is pleased to endorse the NCCN

Guidelines for Patients with breast cancer. This

guide provides valuable, evidence-based, expert-

reviewed information on the standard of care,

empowering patients to make informed decisions

about their treatment.

www.facingourrisk.org

LIVING BEYOND BREAST CANCER

Receiving a diagnosis of breast cancer is

overwhelming. Having trusted information is

essential to help understand one’s particular

diagnosis and treatment options. The information

found in the NCCN Guidelines for Patients:

Breast Cancer is accessible, accurate, and will

help every step of the way—from the moment of

diagnosis through treatment. People can use the

NCCN Guidelines for Patients: Breast Cancer to

become an informed partner in their own care.

www.lbbc.org

sharshEret

Sharsheret is proud to endorse this important

resource, the NCCN Guidelines for Patients:

Breast Cancer. With this critical tool in hand,

women nationwide have the knowledge they

need to partner with their healthcare team to

navigate the often complicated world of breast

cancer care and make informed treatment

decisions.

www.sharsheret.org

Young survival coalition (YSC)

Young Survival Coalition (YSC) is pleased to

endorse the NCCN Guidelines for Patients:

Breast Cancer as an invaluable resource for

young women diagnosed with breast cancer and

their co-survivors. This in-depth, illustrated series

clearly explains what breast cancer is, how it

is treated and what patients can expect on the

journey ahead

. www.youngsurvival.org

Special thank you to

ROCKIN' FOR THE

CURE

®

NCCN Foundation would like to

thank Rockin' for the Cure for

providing much needed support

for the NCCN Guidelines for Patients! Rockin' For

The Cure 2016 was a giant success and we are

incredibly grateful to the Rockin' For The Cure

team for their hard work and passion to promote

cancer awareness. We look forward to 2017.

www.rockinforthecure.net

NCCN Foundation

®

gratefully acknowledges:

Breast Cancer

Carcinoma in Situ

Stage 0